Cart
sales@molnova.com
Zelminemab
CAS No. 2225850-33-7
Zelminemab( —— )
Catalog No. M36779 CAS No. 2225850-33-7
Zelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 603 | In Stock |
|
| 10MG | 1026 | In Stock |
|
| 25MG | 1501 | In Stock |
|
| 50MG | 2009 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZelminemab
-
NoteResearch use only, not for human use.
-
Brief DescriptionZelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
-
DescriptionZelminemab (AMG-301) is a human monoclonal antibody that inhibits PACAP type I (PAC1) receptor.
-
In Vitro——
-
In VivoAnimal Model:Sprague-Dawley rats, electricalstimulation was performed on the intact dura mater abovethe middle meningeal artery.Dosage:10 mg/kg Administration:i.v.; once Result:Induced an inhibition of stimulus-evoked nociceptive activity in the trigeminocervical com-plex (TCC).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225850-33-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Eloisa Rubio-Beltrán, et al. PACAP38 and PAC1 receptor blockade: a new target for headache? J Headache Pain. 2018 Aug 7;19(1):64. ?
molnova catalog
related products
-
Euchrestaflavanone B
Euchrestaflavanone B shows antibacterial activity against Gram positive bacteria, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus. Euchrestaflavanone B may function by inhibiting oncogenic disease, at least in part, through the inhibition of protein kinase CKII activity.
-
Ginkgolic acid C13:0
Ginkgolic acid C13: exhibits the highest α-glucosidase inhibitory activity.
-
TAK-981
TAK-981 is a selective the SUMOylation enzymatic cascade inhibitor, has potential immune-activating and antineoplastic activities.
